CML-CAB 2019 I
7th CML-CAB: Amsterdam, The Netherlands, 3-5 March 2019
On 3-5 March 2019, the CML Community Advisory Board (CML-CAB), a workgroup of the CML Advocates Network, hosted its 7th meeting to discuss issues of major concern to the CML community.
CML-CAB Members attending the 7th CML-CAB as patient experts:
- Jan Geissler - Germany- (CML-CAB Co-chair)
- Pat Garcia-Gonzalez - (CML-CAB Co-chair)
- Giora Sharf – Israel and Europe
- Jana Pelouchova - Czech Republic and Central Eastern Europe
- Bahija Gouimi - Africa and the Middle East
- Rita Christensen - Western Europe
- Rod Padua - East Asia and Pacific
- Felice Bombaci – Italy & Western Europe
- Šarūnas Narbutas – CML AN Chair - Eastern Europe
- Mercedes Arteaga, - Latin America
- Yair Bar David (Israel)
- Cornelia Borowczak, Germany Pediatric CML
- Zack Pemberton-Whiteley, United Kingdom & West Europe
- Yong Yoke Choon, Malaysia & Asia
Plus, the CML Advocates Network team Lidija Pecova and Celia Marín.
CML-CAB with Pfizer, Monday 4th March 2019, 14:00 – 18:00
The following topics were discussed during the CML-CAB:
- Pfizer’s Updates: Organization & CML Strategy
- Access
- Bosulif Patient Experience
- TFR Patient Survey Update
- Discussion and Next Steps
Non-confidential minutes of the meeting are available to CML Advocates Network members below:
pdf 7th CMLCAB March 2019 Pfizer Minutes Non-confidential (686 KB)
CML-CAB with Incyte/Takeda 5th March 2019, 08:00 – 15:00
The following topics were discussed during the CML-CAB:
- Collaboration between the CML community and Takeda/Incyte & Partners
- Review of priority projects/engagements lead by Incyte with support of the CML community
- Ponatinib –Access, clinical application and research
- Takeda Commitment to CML, Discussion and Next Steps
Non-confidential minutes of the meeting are available to CML Advocates Network members below.
pdf 7th CML CAB March 2019 Incyte and Takeda Minutes Non-confidential (707 KB)